20% OFF shipping at masskicker.com on orders over $79 + up to 10% OFF products
masskicker.com
home > dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity > dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity
download picture
Increased HGF Expression Induces Resistance to c MET Tyrosine Kinase Inhibitors in Gastric Cancer Anticancer Research The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Activated HGF c Met Axis in Head and Neck Cancer The Therapeutic Targeting of HGF c Met Signaling in Hepatocellular Carcinoma: Alternative Approaches HGF c Met pathway facilitates the perineural invasion of pancreatic cancer by activating the mTOR NGF axis Cell Death & Disease
Shopping security

Shopping security

Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits  extrahepatic cholangiocarcinoma progression and restores gemcitabine  therapeutic sensitivity
dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits  extrahepatic cholangiocarcinoma progression and restores gemcitabine  therapeutic sensitivity
dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits  extrahepatic cholangiocarcinoma progression and restores gemcitabine  therapeutic sensitivity
dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits  extrahepatic cholangiocarcinoma progression and restores gemcitabine  therapeutic sensitivity
dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits  extrahepatic cholangiocarcinoma progression and restores gemcitabine  therapeutic sensitivity

dihexa cancer risk hgf c-met Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity

Item no : 10291203384
sold recently : Login >>
US$ 21.47
Pay in 4 interest-free payments of $5.37 Learn more
Min. order: 1piece

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jun 20 - Jun 25

Enjoy 20% off shipping

US$ 21.47

1-11

US$ 19.32

12-35

US$ 15.03

36-59

US$ 12.88

60+

US$40

Get now

Sign up to your membership to get coupons up to

15%

Get now

Opportunity to enjoy order discount up to 15% off

Please add the products
Shipping Notes
  • Free Standard Shipping on $100+ Orders to the USA.
  • Except Preorder products are shipped in 48 hours.
  • Delivery to the USA:
  1. Standard Shipping : 3-10 business days
  • If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

Discover Niche Categories That Outsell dihexa cancer risk hgf c-met

Top-Converting Item to Boost Your Average Order

recommand products